WTA
TMO icon

Washington Trust Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Washington Trust Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Sell
2,787
-83
-3% -$39.8K 0.1% 101
2026
Q1 		$1.41M Buy
2,870
+13
+0.5% +$7.05K 0.11% 98
2025
Q4 		$1.66M Sell
2,857
-40
-1% -$22.6K 0.13% 88
2025
Q3 		$1.41M Buy
2,897
+186
+7% +$86.6K 0.11% 97
2025
Q2 		$1.1M Buy
2,711
+44
+2% +$18.4K 0.09% 96
2025
Q1 		$1.33M Sell
2,667
-1,721
-39% -$932K 0.12% 85
2024
Q4 		$2.28M Buy
4,388
+3,102
+241% +$1.71M 0.19% 70
2024
Q3 		$795K Buy
1,286
+76
+6% +$45K 0.07% 107
2024
Q2 		$669K Buy
1,210
+113
+10% +$64.7K 0.06% 112
2024
Q1 		$637K Sell
1,097
-44
-4% -$24.7K 0.06% 111
2023
Q4 		$606K Sell
1,141
-76
-6% -$36.8K 0.06% 114
2023
Q3 		$616K Buy
1,217
+123
+11% +$65.5K 0.06% 114
2023
Q2 		$571K Buy
1,094
+9
+0.8% +$4.86K 0.06% 117
2023
Q1 		$625K Sell
1,085
-12
-1% -$6.76K 0.06% 115
2022
Q4 		$604K Sell
1,097
-173
-14% -$91.7K 0.07% 115
2022
Q3 		$644K Buy
1,270
+61
+5% +$34.1K 0.06% 122
2022
Q2 		$657K Sell
1,209
-3,164
-72% -$1.74M 0.06% 120
2022
Q1 		$2.58M Sell
4,373
-105
-2% -$60.3K 0.18% 82
2021
Q4 		$2.99M Buy
+4,478
New +$2.8M 0.2% 78

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Washington Trust Advisors's TMO Position: Q2 2026 in Review

Washington Trust Advisors reduced its Thermo Fisher Scientific (TMO) stake by 2.9% in Q2 2026, selling an estimated $39.8K and leaving 2,787 shares worth $1.4M. The position accounts for 0.1% of the portfolio, ranked #101.

Washington Trust Advisors first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.99M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Washington Trust Advisors held 2,787 shares of Thermo Fisher Scientific worth $1.4M as of Q2 2026.
  • Washington Trust Advisors sold 83 Thermo Fisher Scientific shares in Q2 2026, an estimated $39.8K.
  • Thermo Fisher Scientific made up 0.1% of Washington Trust Advisors's portfolio in Q2 2026, its #101 holding.
  • Washington Trust Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • Washington Trust Advisors's Thermo Fisher Scientific position peaked at $2.99M in Q4 2021.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.